Extra material I m removing this from the article In June 2006 Mannatech signed a research agreement with Hyperion Biotechnology Inc in which Mannatech agreed to fund a research study related to Ambrotose Mannatech Incorporated Form 10 K SEC Public Filing for FY 2006 Retrieved on April 14 2007 In 2005 the Small Business Administration SBA of the U S federal government certified Hyperion Biotechnology as a small disadvantaged business Hyperion Biotechnology Corporate Web Site About Us Retrieved on April 14 2007 under the SBA s 8 a Business Development Program on the basis that Hyperion Biotechnology is a socially and economically disadvantaged U S Department of Commerce Office of Small and Disadvantaged Business Utilization Information for Small Disadvantaged and 8 a Small Businesses Retrieved on April 14 2007 firm In December 2006 Mannatech signed a research agreement with St George s Hospital Medical School in London England to aid in the funding of a three year clinical trial related to dosing and optimization study on Ambrotose Mannatech Incorporated Form 10 K SEC Public Filing for FY 2006 Retrieved on April 14 2007 The information about Hyperion is immaterial and the remainder doesn t contribute to the content of the article It just lists things that Mannatech has done I left the press release because it made an actual statement but the rest of this is unwarranted in this article